CClinicalTrials.gg
TerminatedNCT02362100Updated May 17, 2021

Proximal Humerus Fractures Randomized Control Trial

An interventional study of Non operative and locking plate surgical fixation in Proximal Humerus Fracture, sponsored by Ottawa Hospital Research Institute. Terminated at 1 site in Canada. Open to participants aged 60 Years and older. Per ClinicalTrials.gov, last updated 2021-05-17.

Sponsored by Ottawa Hospital Research Institute · Not applicable, Interventional, and Treatment

Why this study was terminated
Due to low recruitment, lack of funding, and challenges maintaining follow-up in this patient population, a decision was made to terminate this study.
Phase
Not applicable
Study type
Interventional
Enrollment
30
Allocation
Randomized
Ages
60 Years and older
Sex
All
01

Study summary

The primary objective is to determine if a difference exists in functional outcomes, as measured by the Constant score, when comparing nonoperative management and locking plate surgical fixation of low-energy displaced proximal humerus fractures in the elderly population over a 2-year follow-up period. Secondary outcomes will include an assessment of the ASES score, the SF-36 quality of life score, complication rates, re-operation rates, radiographic time to union, radiographic malunion, hardware position and evidence of avascular necrosis or posttraumatic osteoarthritis .

Read the detailed description

The design of this study is two-fold. The main study will be a prospective, single blind, randomized controlled trial (RCT). Patients will be randomized to either (1) non-operative treatment or (2) locking plate open reduction and internal fixation (ORIF).

The second component of this study will be a prospective, cohort study. This option will be presented to patients who do not want to enroll in the RCT because they prefer one treatment option over the other, and do not wish to be randomized to a treatment. Patients who choose either non-operative treatment or ORIF for their proximal humerus fracture will be followed for 2 years post injury.

Study Objectives:

Objective 1: Does a difference exist in the functional outcome between non-operative management and locking plate surgical fixation of low-energy displaced two-part, three-part, and four-part proximal humerus fractures in the elderly population based on the Constant functional outcome score over a 2-year follow-up period? Objective 2: Does a difference exist between non-operative management and locking plate surgical fixation of low-energy displaced two-part, three-part, and four-part proximal humerus fractures in the elderly population based on the ASES functional outcome score, the short form Patient Reported Outcomes Measurement Information System (PROMIS) upper extremity score, the International Physical Activity Questionnaire (IPAQ) for the elderly, and the EuroQol EQ-5D-5L Health Questionnaire Quality of Life (QoL) functional outcome score over a 2-year follow-up period? What is the incidence of complications of non-operative management and locking plate surgical fixation of low-energy displaced two-part, three-part, and four-part proximal humerus fractures in the elderly population based on infection, nerve injury, intra-articular screw penetration and bleeding (hematoma), reoperation rate, or hospital readmission over a 2-year follow-up period? Objective 3: Does a difference exist between non-operative management and locking plate surgical fixation of low-energy displaced two-part, three-part, and four-part proximal humerus fractures in the elderly population based on radiographic outcomes including non-union, malunion, and joint arthrosis? Objective 4: Does the degree of initial displacement or angulation of the fracture fragments correlate with final functional outcome measures? Objective 5: Does the quality of the surgical reduction correlate with final functional outcome measures?

02

Conditions studied

  • Proximal Humerus Fracture
03

In context

Fractures, Bone

2,261 studies on the registry are indexed under Fractures, Bone; 325 are open to participants now.

This study's enrollment of 30 is below the median of 69 across 1,482 interventional studies indexed under Fractures, Bone.

Browse Fractures, Bone studies →

Lead sponsor

Ottawa Hospital Research Institute is the lead sponsor of 538 studies on the registry; 100 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
60 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  1. Displaced 2- or 3-part proximal humerus fractures by the Neer classification.
  2. Displaced 4-part proximal humeral fractures by the Neer classification that are deemed amenable to surgical fixation.
  3. > 60 years of age
  4. Low energy mechanism of injury
  5. Acute fracture (\<3 weeks)

Exclusion criteria

Exclusion Criteria:

  1. 4-part proximal humerus fractures that are not deemed amenable to surgical fixation (eg. due to osteopenic bone, thin head or tuberosity fragments); fractures that are better suited to treatment with arthroplasty
  2. Isolated greater tuberosity fractures
  3. Ipsilateral upper extremity significant injury, concomitant fracture or polytrauma
  4. Open fracture
  5. Previous ipsilateral shoulder surgery
  6. Patients with active worker's compensation claims (due to the expectation of lower rates of success in this patient population)
  7. Active joint or systemic infection
  8. Patients with convulsive disorders, collagen diseases, and any other conditions that might affect the mobility of the shoulder joint
  9. Major medical illness (life expectancy less than 2 years, unacceptably high operative risk, or not medically cleared by preoperative anesthesia consult)
  10. Unable to speak or read English/French
  11. Psychiatric illness that precludes informed consent
  12. Unwilling to be followed for 2 years
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
30 participants (actual)

Study arms

  • Placebo comparator
    nonoperative management

    Treatment will consist of sling immobilization for a period of 6 weeks. Details and treatment timeline as follows: * 0 - 3 weeks: immobilization with a shoulder sling, range of motion of elbow, hand and wrist * 3 - 6 weeks: same as 0-3 weeks, with addition of pendulum exercises every two hours * After 6 weeks: Active mobilization and removal of sling. Light activity permitted and physiotherapy for range of motion permitted as tolerated. * After 6 months: no further restriction will be placed. Full home and work activity permitted.

    Other: Non operative

  • Active comparator
    locking plate surgical fixation

    Standardized operative management protocol as follows: * Pre-operative medical clearance established via anesthesia consults if required for medically complex patients. * Provision of pre-operative intravenous (IV) antibiotic prophylaxis: * Administration of general anesthetic. * Patient positioning and preparation: * Patient is carefully placed in the beach-chair position, * Deltopectoral approach Fracture reduction and fixation with confirmation with intraoperative fluoroscopy images.

    Procedure: locking plate surgical fixation

Interventions

  • OtherNon operative

    non operative treatment

  • Procedurelocking plate surgical fixation
06

What researchers measure

Primary outcomes

  1. Change in Constant Score

    The Constant Score reflects an overall clinical functional assessment. This instrument is based on a 100-point scoring system. Subjective findings (pain, activities of daily living, and working in different positions) make up a total of 35 points. Objective measurements make up the remaining 65 points.The test is divided into four sub-categories: (1) pain is measured using 4 likert levels (15 points maximum), where a higher score indicates a better outcome; activities of daily living are measured using a likert scale, where a higher number indicates better outcomes (20 points maximum); mobility is measured by an assessor, and rated using a likert scale where a higher score indicates better outcomes (40 points maximum); finally, strength is measured by an assessor where 1 point is given per 0.5kg of force (maximum 25 points), a higher score indicates better outcomes. All categories are added together, and a total score out of 100 is given (higher score indicates better outcome).

    Time frame: From baseline to up until 24-Months Post-Operative

Secondary outcomes

  1. Change in American Shoulder and Elbow Surgeons Standardized Shoulder Assessment

    The ASES is a shoulder specific assessment divided into two sections: pain and activities of daily living (ADL). Pain is recorded on a visual analogue scale (0-10), lower scores indicate better outcomes. There are 10 activities of daily living questions, each are recorded on a 4 level likert scale (0-3), which a higher score indicates a better outcome. The overall score is an equal weight of the two sections and produces a score out of 100. The higher the score, the better the outcome.

    Time frame: From baseline to up until 24-Months Post-Operative

  2. Change in Short Form-36

    The Short Form 36 (SF-36) is an outcome measure used to determine quality of life. This measure has 8 scaled scores, each question has equal weight and is then translated onto a scale graded from 0-100. A higher number indicates a better outcome.

    Time frame: From baseline to up until 24-Months Post-Operative

07

Study locations

1 site
  • The Ottawa Hospital
    Ottawa, Ontario K1H8L6, Canada
08

References and documents

Publications

  • Handoll HH, Elliott J, Thillemann TM, Aluko P, Brorson S. Interventions for treating proximal humeral fractures in adults. Cochrane Database Syst Rev. 2022 Jun 21;6(6):CD000434. doi: 10.1002/14651858.CD000434.pub5. PubMed 35727196 ↗
  • Howard L, Berdusco R, Momoli F, Pollock J, Liew A, Papp S, Lalonde KA, Gofton W, Ruggiero S, Lapner P. Open reduction internal fixation vs non-operative management in proximal humerus fractures: a prospective, randomized controlled trial protocol. BMC Musculoskelet Disord. 2018 Aug 18;19(1):299. doi: 10.1186/s12891-018-2223-3. PubMed 30121091 ↗

Individual participant data

Plan to share: No

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on May 17, 2021, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT02362100
Lead sponsor
Ottawa Hospital Research Institute
Responsible party
Sponsor
First posted
Feb 12, 2015
Start date
Sep 2015
Primary completion
Jan 2021
Completion
Jan 2021
Last update
May 17, 2021

Study contacts

Peter Lapner, MD
principal investigator · The Ottawa Hospital

Oversight

Data monitoring committee
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is terminated, as verified in May 2021. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion